These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 35278027)
1. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study. Ricar J; Cetkovska P; Hordinsky M; Ricarova R Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027 [TBL] [Abstract][Full Text] [Related]
2. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Barrón-Hernández YL; Tosti A Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599 [TBL] [Abstract][Full Text] [Related]
3. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444 [TBL] [Abstract][Full Text] [Related]
4. Bimatoprost in the treatment of eyelash universalis alopecia areata. Vila TO; Camacho Martinez FM Int J Trichology; 2010 Jul; 2(2):86-8. PubMed ID: 21712909 [TBL] [Abstract][Full Text] [Related]
5. Bimatoprost in the treatment of eyelash hypotrichosis. Law SK Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss. Ahluwalia GS J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568 [TBL] [Abstract][Full Text] [Related]
7. Regrowth of upper eyelid eyelashes after making a surgical incision on the upper eyelid in a case of severe alopecia areata. Ning B; Dharmasena A; Inkster C Ophthalmic Plast Reconstr Surg; 2014; 30(1):e2-3. PubMed ID: 23467284 [TBL] [Abstract][Full Text] [Related]
8. An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects. Borchert M; Bruce S; Wirta D; Yoelin SG; Lee S; Mao C; VanDenburgh A Clin Ophthalmol; 2016; 10():419-29. PubMed ID: 27022239 [TBL] [Abstract][Full Text] [Related]
9. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919 [TBL] [Abstract][Full Text] [Related]
10. Eyelash alopecia areata: case series and literature review. Modjtahedi BS; Kishan AU; Schwab IR; Jackson WB; Maibach HI Can J Ophthalmol; 2012 Aug; 47(4):333-8. PubMed ID: 22883840 [TBL] [Abstract][Full Text] [Related]
11. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023 [No Abstract] [Full Text] [Related]
12. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth. Yoelin S; Walt JG; Earl M Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751 [TBL] [Abstract][Full Text] [Related]
13. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies. Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895 [TBL] [Abstract][Full Text] [Related]
14. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits. Giannico AT; Lima L; Russ HH; Montiani-Ferreira F J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234 [TBL] [Abstract][Full Text] [Related]
15. Management of hypotrichosis of the eyelashes: focus on bimatoprost. Fagien S Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474 [TBL] [Abstract][Full Text] [Related]
16. Management of hypotrichosis of the eyelashes: Focus on bimatoprost. Fagien S Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058 [TBL] [Abstract][Full Text] [Related]
17. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface. Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. Faghihi G; Andalib F; Asilian A Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039 [TBL] [Abstract][Full Text] [Related]
19. Long-term utility and durability of the therapeutic effects of bimatoprost 0.03% for eyelash augmentation in healthy Asian subjects. Kwon O; Kim JY; Paik SH; Jeon HC; Jung YJ; Lee Y; Baek JH; Chun JH; Lee WS; Lee JY; Rogers JD; Halstead M; Eun HC Dermatology; 2014; 229(3):222-9. PubMed ID: 25228046 [TBL] [Abstract][Full Text] [Related]
20. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata. Ochoa BE; Sah D; Wang G; Stamper R; Price VH J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021 [No Abstract] [Full Text] [Related] [Next] [New Search]